The 2023 guidelines further solidified SGLT2 is as first-line agents and GLP-1 RAs as an adjunctive in managing high-risk patients, particularly those with atherosclerotic CVD (ASCVD), HF, or CKD, independent of HbA1C and metformin use
Tirzepatide produced 47% greater weight loss than semaglutide at maximum doses over the study period
Many users dose in morning and evening.[reddit] How Should I Store Klow
Constipation is the second most common complaint and often the most persistent
I distinctly remember weighing in at 199lbs when I went on my first diet in high school at age 16 ( heyyy WW ) and lost down to abut 170lbs for my junior year (that was a *great* year for my basketball prospects, by the way)
Eur Heart J 44(39):40434140 Oettinger V, Hehn P, Bode C et al (2023) Center Volumes Correlate with Likelihood of Stent Implantation in German Coronary Angiography